📰 Primary Iga News

Primary Iga News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Primary Iga. Real-time updates on events, politics, business and more.

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (2)

October 19, 2023

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX)...

United States Stanford Healthcaredate Richard Philipson Hong Zhangdate Thierry Christophedate Nadia Nawaz

Source: europapress.es

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023

October 19, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced seven abstract presentations, including a...

United States Hong Zhang Roisin Thomas Richard Philipson Jonathan Barratt Thierry Christophe

Source: prnewswire.com

Calliditas Therapeutics to Present Seven Abstracts at the American Society of Nephrology (ASN) Kidney Week 2023 (1)

October 19, 2023

STOCKHOLM, Oct. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX)...

United States Richard Philipson Stanford Healthcaredate Hong Zhangdate Thierry Christophedate Jonathan Barratt

Source: europapress.es

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN) Tokyo 2023

September 29, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas"), today announced the presentations of new biomarker and...

Richard Phillipson International Symposium On Ig International Symposium On Iga Nephropathy Iiga Primary Iga International Symposium Iga Nephropathy

Source: prnewswire.com

Calliditas Presents Data from the NefIgArd Phase 3 trial at the 17th International Symposium on IgA Nephropathy (IIgANN)

September 29, 2023

STOCKHOLM, Sept. 29, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm:...

Richard Phillipson International Symposium On Ig International Symposium On Iga Nephropathy Iiga Primary Iga International Symposium Iga Nephropathy

Source: europapress.es

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Calliditas Therapeutics to Present Nefecon Data at the 17th International Symposium on IgA Nephropathy (IIgANN) Septembe

September 19, 2023

STOCKHOLM, Sept. 19, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm:...

Hong Zhang Richard Lafayette Heathern Reich Andrew Stone Vladimir Tesar Nadia Nawaz

Source: europapress.es

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (1)

August 15, 2023

STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...

United States United Kingdom Jonathanm Barratt United States Federal Drug Administration European Union Member States University Of Leicester

Source: europapress.es

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet

August 15, 2023

/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced publication in The Lancet of the full data...

United Kingdom United States Jonathanm Barratt European Commission Exchange Commission United States Federal Drug Administration

Source: prnewswire.com

Calliditas Therapeutics announces full results from the NefIgArd Phase 3 trial published in The Lancet (2)

August 15, 2023

STOCKHOLM, Aug. 15, 2023 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX)...

United Kingdom United States Jonathanm Barratt University Of Leicester European Union Member States United States Federal Drug Administration

Source: europapress.es

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Primary Iga News Today

Stay Updated with Latest News

Explore More Categories